NOK 14.0
(-6.35%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -35.34 Million NOK | -104.12% |
2022 | -17.31 Million NOK | -8.7% |
2021 | -15.93 Million NOK | -548.22% |
2020 | -2.45 Million NOK | 63.54% |
2019 | -6.74 Million NOK | 22.8% |
2018 | -8.73 Million NOK | -155.47% |
2017 | -3.41 Million NOK | 31.41% |
2016 | -4.98 Million NOK | 31.15% |
2015 | -7.23 Million NOK | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -18.68 Million NOK | -43.57% |
2024 Q1 | -13.01 Million NOK | 15.01% |
2023 Q3 | -6.65 Million NOK | 11.57% |
2023 Q1 | -6.37 Million NOK | 26.43% |
2023 Q4 | -15.31 Million NOK | -130.03% |
2023 FY | -35.34 Million NOK | -104.12% |
2023 Q2 | -7.52 Million NOK | -18.06% |
2022 Q4 | -8.66 Million NOK | -6925.67% |
2022 Q2 | -1.62 Million NOK | 0.0% |
2022 FY | -17.31 Million NOK | -8.7% |
2022 Q3 | 127.02 Thousand NOK | 107.81% |
2021 FY | -15.93 Million NOK | -548.22% |
2020 FY | -2.45 Million NOK | 63.54% |
2019 FY | -6.74 Million NOK | 22.8% |
2018 FY | -8.73 Million NOK | -155.47% |
2017 FY | -3.41 Million NOK | 31.41% |
2016 FY | -4.98 Million NOK | 31.15% |
2015 FY | -7.23 Million NOK | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Gentian Diagnostics ASA | -12.76 Million NOK | -176.976% |
Medistim ASA | 131.44 Million NOK | 126.892% |